174 related articles for article (PubMed ID: 31595713)
1. Association of statin use with risk of Gleason score-specific prostate cancer: A hospital-based cohort study.
Wang K; Gerke TA; Chen X; Prosperi M
Cancer Med; 2019 Dec; 8(17):7399-7407. PubMed ID: 31595713
[TBL] [Abstract][Full Text] [Related]
2. BMI trajectories and risk of overall and grade-specific prostate cancer: An observational cohort study among men seen for prostatic conditions.
Wang K; Chen X; Gerke TA; Bird VY; Ghayee HK; Prosperi M
Cancer Med; 2018 Oct; 7(10):5272-5280. PubMed ID: 30207080
[TBL] [Abstract][Full Text] [Related]
3. The risk of prostate cancer for men on aspirin, statin or antidiabetic medications.
Nordström T; Clements M; Karlsson R; Adolfsson J; Grönberg H
Eur J Cancer; 2015 Apr; 51(6):725-33. PubMed ID: 25727881
[TBL] [Abstract][Full Text] [Related]
4. Blood cholesterol, tumor clinical characteristics and risk of prostate cancer progression after radical prostatectomy.
Rantaniemi L; Tammela TLJ; Kujala P; Murtola TJ
Scand J Urol; 2018 Aug; 52(4):269-276. PubMed ID: 30362865
[TBL] [Abstract][Full Text] [Related]
5. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease.
Grytli HH; Fagerland MW; Fosså SD; Taskén KA
Eur Urol; 2014 Mar; 65(3):635-41. PubMed ID: 23351721
[TBL] [Abstract][Full Text] [Related]
6. Use of statins and prostate cancer recurrence among patients treated with radical prostatectomy.
Chao C; Jacobsen SJ; Xu L; Wallner LP; Porter KR; Williams SG
BJU Int; 2013 May; 111(6):954-62. PubMed ID: 23464862
[TBL] [Abstract][Full Text] [Related]
7. The impact of statins in combination with androgen deprivation therapyin patients with advanced prostate cancer: A large observational study.
Anderson-Carter I; Posielski N; Liou JI; Khemees TA; Downs TM; Abel EJ; Jarrard DF; Richards KA
Urol Oncol; 2019 Feb; 37(2):130-137. PubMed ID: 30528885
[TBL] [Abstract][Full Text] [Related]
8. Postdiagnostic Statin Use and the Risk of Lethal Prostate Cancer in the Health Professionals Follow-up Study.
Chan JM; Kenfield SA; Paciorek A; Platz EA; Giovannucci EL; Stampfer MJ
Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1638-40. PubMed ID: 26189767
[TBL] [Abstract][Full Text] [Related]
9. The effect of statin use on the incidence of prostate cancer: A population-based nested case-control study.
Dawe DE; Ye X; Czaykowski P; Jassal D; Singh H; Skarsgard D; Aprikian A; Mahmud SM
Int J Cancer; 2018 Jul; 143(1):190-198. PubMed ID: 29405283
[TBL] [Abstract][Full Text] [Related]
10. Statin use and prostate cancer risk in a large population-based setting.
Boudreau DM; Yu O; Buist DS; Miglioretti DL
Cancer Causes Control; 2008 Sep; 19(7):767-74. PubMed ID: 18322813
[TBL] [Abstract][Full Text] [Related]
11. Postdiagnosis Statin Use and Mortality in Danish Patients With Prostate Cancer.
Larsen SB; Dehlendorff C; Skriver C; Dalton SO; Jespersen CG; Borre M; Brasso K; Nørgaard M; Johansen C; Sørensen HT; Hallas J; Friis S
J Clin Oncol; 2017 Oct; 35(29):3290-3297. PubMed ID: 28806117
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer survival among statin users after prostatectomy in a Finnish nationwide cohort.
Joentausta RM; Rannikko A; Murtola TJ
Prostate; 2019 May; 79(6):583-591. PubMed ID: 30652328
[TBL] [Abstract][Full Text] [Related]
13. Advancing age within established Gleason score categories and the risk of prostate cancer-specific mortality (PCSM).
Russo AL; Chen MH; Aizer AA; Hattangadi JA; D'Amico AV
BJU Int; 2012 Oct; 110(7):973-9. PubMed ID: 22954029
[TBL] [Abstract][Full Text] [Related]
14. The Suggested Unique Association Between the Various Statin Subgroups and Prostate Cancer.
Goldberg H; Mohsin FK; Saskin R; Kulkarni GS; Berlin A; Kenk M; Wallis CJD; Klaassen Z; Chandrasekar T; Ahmad AE; Sayyid RK; Saarela O; Penn L; Alibhai SMH; Fleshner N
Eur Urol Focus; 2021 May; 7(3):537-545. PubMed ID: 32620539
[TBL] [Abstract][Full Text] [Related]
15. Statin use and risk of prostate cancer: Results from the Southern Community Cohort Study.
Kantor ED; Lipworth L; Fowke JH; Giovannucci EL; Mucci LA; Signorello LB
Prostate; 2015 Sep; 75(13):1384-93. PubMed ID: 26012482
[TBL] [Abstract][Full Text] [Related]
16. Statin use and risk of prostate cancer: a Danish population-based case-control study, 1997-2010.
Jespersen CG; Nørgaard M; Friis S; Skriver C; Borre M
Cancer Epidemiol; 2014 Feb; 38(1):42-7. PubMed ID: 24275259
[TBL] [Abstract][Full Text] [Related]
17. Associations between statin use and progression in men with prostate cancer treated with primary androgen deprivation therapy.
Mikkelsen MK; Thomsen FB; Berg KD; Jarden M; Larsen SB; Hansen RB; Brasso K
Scand J Urol; 2017 Dec; 51(6):464-469. PubMed ID: 28831860
[TBL] [Abstract][Full Text] [Related]
18. Individual and joint effects of metformin and statins on mortality among patients with high-risk prostate cancer.
Tan XL; E JY; Lin Y; Rebbeck TR; Lu SE; Shang M; Kelly WK; D'Amico A; Stein MN; Zhang L; Jang TL; Kim IY; Demissie K; Ferrari A; Lu-Yao G
Cancer Med; 2020 Apr; 9(7):2379-2389. PubMed ID: 32035002
[TBL] [Abstract][Full Text] [Related]
19. Serum cholesterol and prostate cancer risk in the Finnish randomized study of screening for prostate cancer.
Murtola TJ; Kasurinen TVJ; Talala K; Taari K; Tammela TLJ; Auvinen A
Prostate Cancer Prostatic Dis; 2019 Mar; 22(1):66-76. PubMed ID: 30214034
[TBL] [Abstract][Full Text] [Related]
20. Statin use and time to progression in men on active surveillance for prostate cancer.
Jayalath VH; Nayan M; Finelli A; Komisarenki M; Timilshina N; Kulkarni GS; Fleshner NE; Bhindi B; Evans A; Zlotta AR; Hamilton RJ
Prostate Cancer Prostatic Dis; 2018 Nov; 21(4):509-515. PubMed ID: 29875433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
